Is InfuSystem Holdings, Inc. overvalued or undervalued?

As of 12 June 2025, InfuSystem Holdings, Inc. has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its P/E ratio of 47, which significantly exceeds the industry average, and an EV to EBITDA ratio of 8.31. Additionally, the PEG ratio stands at an exceptionally low 0.01, indicating a potential misalignment between growth expectations and current pricing.
In comparison to its peers, InfuSystem's valuation metrics are notably higher; for instance, Universal Technical Institute, Inc. has a P/E of 31.55 and an EV to EBITDA of 13.60, while Emerald Holding, Inc. is at a P/E of 41.37 and an EV to EBITDA of 10.95. These comparisons further reinforce the notion that InfuSystem is overvalued, especially considering its recent stock performance, which has underperformed against the S&P 500 across various time frames, including a year-to-date decline of 26.86% compared to a modest gain of 2.44% for the index.